Does leflunomide attenuate the sepsis-induced acute lung injury?

Pediatric Surgery International

Volumn 24, Issue 8, 2008, Pages 899-905

  Ozturk, Erdogan ^a   Demirbilek, Semra ^a   Begec, Zekine ^a   Surucu, Murat ^a   Fadillioglu, Ersin ^b   Kirimlioglu, Hale ^a   Ersoy, M Ozcan ^a  

^a INONU UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute lung injury; Leflunomide; Oxidative stress; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE PEROXIDASE; KETAMINE; LEFLUNOMIDE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; XYLAZINE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CECUM; CERVICAL SPINE DISLOCATION; CONTROLLED STUDY; EDEMA; ENZYME ACTIVITY; LUNG ALVEOLUS CELL; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; SEPSIS;

ACUTE LUNG INJURY; ADJUVANTS, IMMUNOLOGIC; ANIMALS; DISEASE MODELS, ANIMAL; GLUTATHIONE; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LUNG; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SEPSIS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 48549101190     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-008-2184-y     Document Type: Article

References (32)

1. CW Chow MT Herrera Abreu T Suzuki GP Downey 2003 Oxidative stress and acute lung injury Am J Respir Cell Mol Biol 29 427 431 10.1165/rcmb.F278
2. JD Lang PJ McArdle PJ O'Reilly S Matalon 2002 Oxidant-antioxidant balance in acute lung injury Chest 122 314 320 10.1378/chest.122.6_suppl.314S
3. BT Thompson 2003 Glucocorticoids and acute lung injury Crit Care Med 31 253 257 10.1097/01.CCM.0000057900.19201.55
4. S Manocha D Feinstein A Kumar A Kumar 2002 Novel therapies for sepsis: antiendotoxin therapies Expert Opin Investig Drugs 11 1795 1812 10.1517/13543784.11.12.1795
5. SK Leeper-Woodford PD Carey K Byrne JK Jenkins BJ Fisher C Blocher 1991 Tumor necrosis factor. Alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury Am Rev Respir Dis 143 1076 1082
6. RG Brower LB Ware Y Berthiaume MA Matthay 2001 Treatment of ARDS Chest 120 1347 1367 10.1378/chest.120.4.1347
7. E Silverman L Spiegel D Hawkins R Petty D Goldsmith L Schanberg 2005 Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis Arthritis Rheum 52 554 562 10.1002/art.20861
8. AS Kalgutkar HT Nguyen AD Vaz A Doan DK Dalvie DG McLeod 2003 In vitro metabolism studies on the isoxazole ring scission in the anti-inflammatory agent lefluonomide to its active alpha-cyanoenol metabolite A771726: mechanistic similarities with the cytochrome P450-catalyzed dehydration of aldoximes Drug Metab Dispos 31 1240 1250 10.1124/dmd.31.10.1240
9. L Zhang Z Qi D Wu S Shan H Ekberg 2004 Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection Scand J Immunol 59 255 260 10.1111/j.0300-9475.2004.01401.x
10. HW Yao J Li JQ Chen SY Xu 2004 Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats Acta Pharmacol Sin 25 7 915 20
11. AS Chong W Huang W Liu J Luo J Shen W Xu 1999 In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression Transplantation 68 100 109 10.1097/00007890-199907150-00020
12. KA Wichterman AE Baue IH Chaudry 1980 Sepsis and septic shock-a review of laboratory models and proposal J Surg Res 29 189 201 10.1016/0022-4804(80) 90037-2
13. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with folin phenol reaction J Biol Chem 193 265 271
14. Y Sun LW Oberley Y Li 1988 A simple method for clinical assay of superoxide dismutase Clin Chem 34 497 500
15. H Aebi 1984 Catalase in vitro Methods Enzymol 105 121 126 10.1016/S0076-6879(84)05016-3
16. DE Paglia WN Valentine 1967 Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70 158 170 Medline
17. H Wei K Frenkel 1993 Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters Carcinogenesis 14 1195 1201 10.1093/carcin/14.6.1195
18. H Esterbauer KH Cheeseman 1990 Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal Methods Enzymol 186 407 421 10.1016/0076-6879(90)86134-H
19. NK Cortas NW Wakid 1990 Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method Clin Chem 36 1440 1443
20. RL Levine D Garland CN Oliver A Amici I Climent AG Lenz 1990 Determination of carbonyl content in oxidatively modified proteins Methods Enzymol 186 464 478 10.1016/0076-6879(90)86141-H
21. G Sener H Toklu F Ercan G Erkanli 2005 Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis Int Immunopharmacol 5 1387 1396 10.1016/j.intimp.2005.03.007
22. H Babayigit C Kucuk E Sozuer C Yazici K Kose H Akgun 2005 Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats Intensive Care Med 31 865 870 10.1007/s00134-005-2629-x
23. RF Guo PA Ward 2007 Role of oxidants in lung injury during sepsis Antioxid Redox Signal 9 1991 2002 10.1089/ars.2007.1785
24. J Reutershan K Ley 2004 Bench-to-bedside review: acute respiratory distress syndrome-how neutrophils migrate into the lung Crit Care 8 453 461 10.1186/cc2881
25. VM Victor M Rocha JV Esplugues M De la Fuente 2005 Role of free radicals in sepsis: antioxidant therapy Curr Pharm Des 11 3141 3158 10.2174/ 1381612054864894
26. C Ritter M Andrades ML Frota Júnior F Bonatto RA Pinho M Polydoro 2003 Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation Intensive Care Med 29 1782 1789 10.1007/s00134-003-1789-9
27. S Demirbilek MO Ersoy S Demirbilek A Karaman M Akin M Bayraktar 2004 Effects of polyenylphosphatidylcholine on cytokines, nitrite/nitrate levels, antioxidant activity and lipid peroxidation in rats with sepsis Intensive Care Med 30 1974 1978 10.1007/s00134-004-2234-4
28. A Karaman E Fadillioglu E Turkmen E Tas Z Yilmaz 2006 Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver Pediatr Surg Int 22 428 434 10.1007/s00383-006-1668-x
29. A Karaman M Iraz H Kirimlioglu N Karadag E Tas E Fadillioglu 2006 Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment Pediatr Surg Int 22 701 708 10.1007/s00383-006-1744-2
30. SV Reddy A Wanchu M Khullar S Govindrajan P Bambery 2005 Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis Int Immunopharmacol 5 1085 1090 10.1016/j.intimp.2004.11.013
31. SK Manna BB Aggarwal 1999 Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression J Immunol 162 2095 2102
32. WD Li GX Ran HL Teng ZB Lin 2002 Dynamic effects of leflunomide on IL-1, IL-6, and TNF-alpha activity produced from peritoneal macrophages in adjuvant arthritis rats Acta Pharmacol Sin 23 752 756